Main > ONCOLOGY (**) > Multiple Myeloma R/R *** > Treatment > SE. O. Melphalan Flufenamide+>>

---

SE. O. Melphalan Flufenamide+>>'s subsections
(*) USA Approval Date: 2021. 02.26
+Dexamethasone
>4 prior lines of therapy
>refractory to at least>
Company
Patent>Assigneel Claims; No.; Etc.
Patent>Total USA No.: 5
Patent>UpDate: 2021. 03.02
TradeMark

SE. O. Melphalan Flufenamide+>>'s products
This section has no products